Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses.

Popova L, Smith K, West AH, Wilson PC, James JA, Thompson LF, Air GM.

PLoS One. 2012;7(7):e41895. doi: 10.1371/journal.pone.0041895. Epub 2012 Jul 25.

2.

Changed epitopes drive the antigenic drift for influenza A (H3N2) viruses.

Huang JW, Yang JM.

BMC Bioinformatics. 2011 Feb 15;12 Suppl 1:S31. doi: 10.1186/1471-2105-12-S1-S31.

3.

A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head.

Benjamin E, Wang W, McAuliffe JM, Palmer-Hill FJ, Kallewaard NL, Chen Z, Suzich JA, Blair WS, Jin H, Zhu Q.

J Virol. 2014 Jun;88(12):6743-50. doi: 10.1128/JVI.03562-13. Epub 2014 Apr 2.

4.

Genetic characterization of seasonal influenza A (H3N2) viruses in Ontario during 2010-2011 influenza season: high prevalence of mutations at antigenic sites.

Eshaghi A, Duvvuri VR, Li A, Patel SN, Bastien N, Li Y, Low DE, Gubbay JB.

Influenza Other Respir Viruses. 2014 Mar;8(2):250-7. doi: 10.1111/irv.12219. Epub 2013 Dec 6.

5.

Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.

Wang X, Ilyushina NA, Lugovtsev VY, Bovin NV, Couzens LK, Gao J, Donnelly RP, Eichelberger MC, Wan H.

J Virol. 2017 Jan 3;91(2). pii: e01512-16. doi: 10.1128/JVI.01512-16. Print 2017 Jan 15.

6.

Single hemagglutinin mutations that alter both antigenicity and receptor binding avidity influence influenza virus antigenic clustering.

Li Y, Bostick DL, Sullivan CB, Myers JL, Griesemer SB, Stgeorge K, Plotkin JB, Hensley SE.

J Virol. 2013 Sep;87(17):9904-10. doi: 10.1128/JVI.01023-13. Epub 2013 Jul 3.

7.

Molecular and antigenic evolution of human influenza A/H3N2 viruses in Quebec, Canada, 2009-2011.

Ann J, Papenburg J, Bouhy X, Rhéaume C, Hamelin MÈ, Boivin G.

J Clin Virol. 2012 Jan;53(1):88-92. doi: 10.1016/j.jcv.2011.09.016. Epub 2011 Oct 28.

PMID:
22036039
8.

Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies.

Rockman S, Camuglia S, Vandenberg K, Ong C, Baker MA, Nation RL, Li J, Velkov T.

Mol Immunol. 2013 Apr;53(4):435-42. doi: 10.1016/j.molimm.2012.10.001. Epub 2012 Nov 3.

PMID:
23127859
9.

Progressive antigenic drift and phylogeny of human influenza A(H3N2) virus over five consecutive seasons (2009-2013) in Hangzhou, China.

Shao TJ, Li J, Yu XF, Kou Y, Zhou YY, Qian X.

Int J Infect Dis. 2014 Dec;29:190-3. doi: 10.1016/j.ijid.2014.09.013. Epub 2014 Oct 31.

10.

Deep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans.

Dinis JM, Florek NW, Fatola OO, Moncla LH, Mutschler JP, Charlier OK, Meece JK, Belongia EA, Friedrich TC.

J Virol. 2016 Jan 6;90(7):3355-65. doi: 10.1128/JVI.03248-15. Erratum in: J Virol. 2016 Sep 1;90(17):8029.

11.

Antigenic epitopes in the hemagglutinin of Qinghai-type influenza H5N1 virus.

Rudneva IA, Kushch AA, Masalova OV, Timofeeva TA, Klimova RR, Shilov AA, Ignatieva AV, Krylov PS, Kaverin NV.

Viral Immunol. 2010 Apr;23(2):181-7. doi: 10.1089/vim.2009.0086.

PMID:
20373998
12.

Substitutions near the hemagglutinin receptor-binding site determine the antigenic evolution of influenza A H3N2 viruses in U.S. swine.

Lewis NS, Anderson TK, Kitikoon P, Skepner E, Burke DF, Vincent AL.

J Virol. 2014 May;88(9):4752-63. doi: 10.1128/JVI.03805-13. Epub 2014 Feb 12.

13.

Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection.

DeDiego ML, Anderson CS, Yang H, Holden-Wiltse J, Fitzgerald T, Treanor JJ, Topham DJ.

Immunology. 2016 Jun;148(2):160-73. doi: 10.1111/imm.12594. Epub 2016 Mar 30.

14.

Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.

Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA, Fonseca K, Winter AL, Gubbay JB, Krajden M, Petric M, Charest H, Bastien N, Kwindt TL, Mahmud SM, Van Caeseele P, Li Y.

PLoS One. 2014 Mar 25;9(3):e92153. doi: 10.1371/journal.pone.0092153. eCollection 2014.

15.

A highly conserved neutralizing epitope on group 2 influenza A viruses.

Ekiert DC, Friesen RH, Bhabha G, Kwaks T, Jongeneelen M, Yu W, Ophorst C, Cox F, Korse HJ, Brandenburg B, Vogels R, Brakenhoff JP, Kompier R, Koldijk MH, Cornelissen LA, Poon LL, Peiris M, Koudstaal W, Wilson IA, Goudsmit J.

Science. 2011 Aug 12;333(6044):843-50. doi: 10.1126/science.1204839. Epub 2011 Jul 7.

16.

Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies.

Kaverin NV, Rudneva IA, Govorkova EA, Timofeeva TA, Shilov AA, Kochergin-Nikitsky KS, Krylov PS, Webster RG.

J Virol. 2007 Dec;81(23):12911-7. Epub 2007 Sep 19.

17.

The Molecular Determinants of Antibody Recognition and Antigenic Drift in the H3 Hemagglutinin of Swine Influenza A Virus.

Abente EJ, Santos J, Lewis NS, Gauger PC, Stratton J, Skepner E, Anderson TK, Rajao DS, Perez DR, Vincent AL.

J Virol. 2016 Aug 26;90(18):8266-80. doi: 10.1128/JVI.01002-16. Print 2016 Sep 15.

18.

Genetic and antigenic characterization of hemagglutinin of influenza A/H3N2 virus from the 2015 season in Thailand.

Tewawong N, Suntronwong N, Vichiwattana P, Vongpunsawad S, Theamboonlers A, Poovorawan Y.

Virus Genes. 2016 Oct;52(5):711-5. doi: 10.1007/s11262-016-1347-5. Epub 2016 May 4.

PMID:
27146171
19.

Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses.

Koel BF, Mögling R, Chutinimitkul S, Fraaij PL, Burke DF, van der Vliet S, de Wit E, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Smith DJ, Fouchier RA, de Graaf M.

J Virol. 2015 Apr;89(7):3763-75. doi: 10.1128/JVI.02962-14. Epub 2015 Jan 21.

20.

Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses.

Iba Y, Fujii Y, Ohshima N, Sumida T, Kubota-Koketsu R, Ikeda M, Wakiyama M, Shirouzu M, Okada J, Okuno Y, Kurosawa Y, Yokoyama S.

J Virol. 2014 Jul;88(13):7130-44. doi: 10.1128/JVI.00420-14. Epub 2014 Apr 9.

Supplemental Content

Support Center